Fed Uncertainty Spurs Defensive Dividend Stocks
As market uncertainty surrounding the Federal Reserve's rate decisions continues to grip investors, some experts recommend taking a defensive approach by investing in dividend-paying stocks. Three such large-cap companies that stand out are McCormick & Company, UnitedHealth Group, and CVS Health.
McCormick & Company operates within the consumer staples sector, providing flavor products for households and foodservice customers worldwide. The company boasts a robust revenue stream, with approximately $4.4 billion generated from its Consumer segment and $3.0 billion from Flavor Solutions in 2026. McCormick's market capitalization stands at around $13.9 billion.
Despite its stable financials, the company faces a margin squeeze due to increasing competition and changing consumer preferences. Investors are advised to closely monitor this development as it could impact net margins over the next few years.
UnitedHealth Group is another large-cap defensive dividend stock that offers investors stability and growth potential. The company's diversified healthcare footprint includes insurance and services, making it less susceptible to market fluctuations. UnitedHealth Group generates approximately $346.5 billion from its various segments in 2026, with a market value of around $340.3 billion.
However, the company faces challenges related to Medicare membership profiles, which impacted revenue in 2025. Investors should closely follow how these changes affect the company's margins and long-term income appeal.
CVS Health is another pure-play U.S. healthcare stock that offers investors a defensive dividend play. The company operates an integrated health solutions model across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness segments. CVS Health generates approximately $200.5 billion in revenue from its Health Services segment and has a market value of around $121.1 billion.
Investors should note that CVS Health faced a decline of about 10% after its preliminary Q3 earnings miss, which may impact earnings resilience and dividend comfort. A closer look at the company's longer-term dividend potential is warranted to assess its attractiveness as a defensive investment.